Antibiotic influx and efflux in Pseudomonas aeruginosa: Regulation and therapeutic implications.
Microb Biotechnol
; 17(5): e14487, 2024 May.
Article
em En
| MEDLINE
| ID: mdl-38801351
ABSTRACT
Pseudomonas aeruginosa is a notorious multidrug-resistant pathogen that poses a serious and growing threat to the worldwide public health. The expression of resistance determinants is exquisitely modulated by the abundant regulatory proteins and the intricate signal sensing and transduction systems in this pathogen. Downregulation of antibiotic influx porin proteins and upregulation of antibiotic efflux pump systems owing to mutational changes in their regulators or the presence of distinct inducing molecular signals represent two of the most efficient mechanisms that restrict intracellular antibiotic accumulation and enable P. aeruginosa to resist multiple antibiotics. Treatment of P. aeruginosa infections is extremely challenging due to the highly inducible mechanism of antibiotic resistance. This review comprehensively summarizes the regulatory networks of the major porin proteins (OprD and OprH) and efflux pumps (MexAB-OprM, MexCD-OprJ, MexEF-OprN, and MexXY) that play critical roles in antibiotic influx and efflux in P. aeruginosa. It also discusses promising therapeutic approaches using safe and efficient adjuvants to enhance the efficacy of conventional antibiotics to combat multidrug-resistant P. aeruginosa by controlling the expression levels of porins and efflux pumps. This review not only highlights the complexity of the regulatory network that induces antibiotic resistance in P. aeruginosa but also provides important therapeutic implications in targeting the inducible mechanism of resistance.
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Proteínas de Membrana Transportadoras
/
Pseudomonas aeruginosa
/
Regulação Bacteriana da Expressão Gênica
/
Antibacterianos
Limite:
Humans
Idioma:
En
Revista:
Microb Biotechnol
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
China